What is Relay Therapeutics, Inc.'s net change in cash?

Relay Therapeutics, Inc. (RLAY) reported net change in cash of $120.57M in Q1 2026.

How has Relay Therapeutics, Inc.'s net change in cash changed year-over-year?

Relay Therapeutics, Inc.'s net change in cash increased by 492.2% year-over-year, from -$30.75M to $120.57M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Relay Therapeutics, Inc. RLAY Net Change in Cash

Net Change in Cash at other companies

CelcuityCELC

-$20.51M-240%

Revolution Medicines, Inc.RVMD

$57.19M+127%

Ligand PharmaceuticalsLGND

-$59.83M-146%

Cogent Biosciences, Inc.COGT

-$70.8M-354%

Tango TherapeuticsTNGX

$45.12M+507%

Spyre Therapeutics, Inc.SYRE

$11.46M+128%

Other financials

Income statement

See full

Revenue$3.0M-60.9%

Operating income-$78.6M+7.4%

Net income-$73.3M+4.9%

EPS (diluted)-$0.41+10.9%

Balance sheet

See full

Cash & equivalents$204.6M+119%

Total debt$31.6M-33.1%

Total equity$642.2M-10.9%

Total assets$699.6M-12.5%

Cash flow

See full

Operating cash flow-$51.1M+30.2%

CapEx$1.0K—

Free cash flow-$44.9M+22.5%

Valuation

See full

Market cap$3.46B+300%

Enterprise value$3.29B+304%

P/S324.1×+212×

Profitability

See full

Operating margin-2,776.6%-820pp

Net margin-2,554.1%-745pp

FCF margin-1,536%-429pp

Returns & leverage

See full

Return on equity-40%-4.3pp

Debt / equity0×0.0×

Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s net change in cash?: Relay Therapeutics, Inc. (RLAY) reported net change in cash of $120.57M in Q1 2026.
How has Relay Therapeutics, Inc.'s net change in cash changed year-over-year?: Relay Therapeutics, Inc.'s net change in cash increased by 492.2% year-over-year, from -$30.75M to $120.57M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.